Operational Pathways for Biomarker Testing in NSCLC
Update: 2023-03-21
Description
In this Amgen sponsored podcast, David R. Braxton, MD, Chief of Service for Molecular Pathology at Hoag Hospital, shares his insights as considerations on operationalizing biomarker testing into clinical practice in NSCLC. He discusses considerations on improving the turnaround time of test results, clinical application of ctDNA testing as well as strategies for documentation of results for ease of retrieval.
Sponsored by Amgen
If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
